Lindbrook Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $5.42M | Buy |
6,563
+233
| +4% | +$192K | 0.5% | 30 |
|
2024
Q4 | $4.89M | Sell |
6,330
-519
| -8% | -$401K | 0.44% | 36 |
|
2024
Q3 | $6.07M | Buy |
6,849
+163
| +2% | +$144K | 0.54% | 30 |
|
2024
Q2 | $6.05M | Buy |
6,686
+392
| +6% | +$355K | 0.57% | 29 |
|
2024
Q1 | $4.9M | Buy |
6,294
+136
| +2% | +$106K | 0.46% | 42 |
|
2023
Q4 | $3.59M | Buy |
6,158
+585
| +10% | +$341K | 0.36% | 50 |
|
2023
Q3 | $2.99M | Buy |
5,573
+310
| +6% | +$166K | 0.33% | 51 |
|
2023
Q2 | $2.47M | Buy |
5,263
+254
| +5% | +$119K | 0.26% | 62 |
|
2023
Q1 | $1.72M | Sell |
5,009
-171
| -3% | -$58.7K | 0.2% | 74 |
|
2022
Q4 | $1.89M | Buy |
5,180
+85
| +2% | +$31.1K | 0.23% | 72 |
|
2022
Q3 | $1.65M | Buy |
5,095
+307
| +6% | +$99.2K | 0.28% | 44 |
|
2022
Q2 | $1.55M | Buy |
4,788
+3,548
| +286% | +$1.15M | 0.26% | 49 |
|
2022
Q1 | $355K | Buy |
1,240
+113
| +10% | +$32.4K | 0.05% | 200 |
|
2021
Q4 | $311K | Hold |
1,127
| – | – | 0.05% | 219 |
|
2021
Q3 | $260K | Buy |
1,127
+33
| +3% | +$7.61K | 0.07% | 123 |
|
2021
Q2 | $251K | Sell |
1,094
-557
| -34% | -$128K | 0.06% | 140 |
|
2021
Q1 | $308K | Buy |
1,651
+176
| +12% | +$32.8K | 0.07% | 117 |
|
2020
Q4 | $249K | Sell |
1,475
-45
| -3% | -$7.6K | 0.06% | 122 |
|
2020
Q3 | $225K | Buy |
1,520
+165
| +12% | +$24.4K | 0.06% | 118 |
|
2020
Q2 | $222K | Buy |
1,355
+102
| +8% | +$16.7K | 0.07% | 107 |
|
2020
Q1 | $174K | Sell |
1,253
-263
| -17% | -$36.5K | 0.07% | 114 |
|
2019
Q4 | $199K | Sell |
1,516
-5
| -0.3% | -$656 | 0.07% | 146 |
|
2019
Q3 | $170K | Buy |
1,521
+68
| +5% | +$7.6K | 0.06% | 159 |
|
2019
Q2 | $160K | Sell |
1,453
-278
| -16% | -$30.6K | 0.06% | 165 |
|
2019
Q1 | $224K | Buy |
1,731
+827
| +91% | +$107K | 0.09% | 113 |
|
2018
Q4 | $104K | Buy |
+904
| New | +$104K | 0.05% | 195 |
|